RAD51D and cancer: Of the eight HRR genes examined, the median methylation observed at the promoter regions of RAD51D and XRCC3 was ≤25% in all samples across all cancer types assessed (Supplementary Figures S2-S10), suggesting absence of promoter methylation for these two genes.